The Patent Finder

Vesta Therapeutics, Inc.

Also on record
Records under this name other than the patents Vesta Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to Vesta Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,877,497Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 7,413,897Primitive and Proximal Hepatic Stem Cells
Term ended
Term ended Mar 14, 2023 · High confidence
Term endedTerm ended Mar 14, 2023High confidence
US 8,691,523Primitive and proximal hepatic stem cells
Lapsed on the fee record
Ended Apr 8, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 8, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited